Incyte (INCY) Tax Rate (2010 - 2026)
Incyte's (INCY) quarterly Tax Rate came in at 22.08% in Q2 2026, down 534.0% YoY from 5.09% in Q2 2025, and up 88.37% on a QoQ basis from 11.72% in Q1 2026.
Powered by 
Analysis
Incyte (INCY) Tax Rate (2010 - 2026) Analysis & Trends
Incyte (INCY) has 16 years of Tax Rate data on file, last reported at 22.08% in Q2 2026.
- Quarterly Tax Rate fell 534.0% year-over-year to 22.08% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 18.04% (down 1297.0% YoY) and the FY2025 annual result came in at 22.7%, down 6700.0% from the prior year.
- Tax Rate advanced to 22.08% in Q2 2026, from 11.72% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 64.7% in Q4 2022 to a low of 14.07% in Q2 2024.
- A 5-year average of 28.49% and a median of 27.08% in 2025 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2022 — Tax Rate soared 43450 bps — and 2024, when it slumped 4074 bps.
- Tracing INCY's Tax Rate over 5 years: stood at 64.7% in 2022, then sank by 60 bps to 25.79% in 2023, then surged by 39 bps to 35.86% in 2024, then slumped by 35 bps to 23.25% in 2025, then decreased by 5 bps to 22.08% in 2026.
- The last three Tax Rate figures came in at 22.08% (Q2 2026), 11.72% (Q1 2026), and 23.25% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.70 Bn | 58.52 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 57.56 Bn | 52.42 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.16 Bn | 35.06 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.63 Bn | 32.32 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.63 Bn | 27.79 Bn | - | - |
| 9 | Insmed | 27.73 Bn | 26.57 Bn | 358.27 Mn | -16.71% |
| 10 | Incyte | 25.60 Bn | 21.07 Bn | 1.57 Bn | 22.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.08% |
| Mar 31, 2026 | 11.72% |
| Dec 31, 2025 | 23.25% |
| Sep 30, 2025 | 12.05% |
| Jun 30, 2025 | 27.42% |
| Mar 31, 2025 | 32.45% |
| Dec 31, 2024 | 35.86% |
| Sep 30, 2024 | 31.99% |
| Jun 30, 2024 | -14.07% |
| Mar 31, 2024 | 28.21% |
| Dec 31, 2023 | 25.79% |
| Sep 30, 2023 | 26.75% |
| Jun 30, 2023 | 26.68% |
| Mar 31, 2023 | 58.15% |
| Dec 31, 2022 | 64.70% |
| Sep 30, 2022 | 24.10% |
| Jun 30, 2022 | 29.62% |
| Mar 31, 2022 | 46.14% |
| Dec 31, 2021 | -369.80% |
| Sep 30, 2021 | 13.24% |